Los Angeles, Feb. 16, 2016 -- Celebrity liposuction expert and lipedema treatment pioneer Dr. David Amron announces the launch of the Anti-Aging & Regenerative programs at The Roxbury Institute in Beverly Hills, California. To kick off the educational series, the first-of-its-kind aesthetics and anti-aging facility will be hosting world-renowned orthopedic surgeon Dr. Michael Price for a rare discussion on non-surgical solutions for joint pain, tonight at 7:00 p.m.
Focused on targeted comprehensive care, The Roxbury Institute features specialists and sub-specialists in nearly every area of aesthetics and anti-aging medicine, including facial and body plastic surgery, high definition body contouring, dermatology, fat transfer, and more. Additionally, it’s highly trusted Anti-Aging Center is home to the foremost experts in hormone replacement, gut health, IV nutrition, stem cell therapy, and nutraceuticals.
“We are extremely enthusiastic about our premier Anti-Aging & Regenerative program at the institute,” said Dr. Amron, founder of The Roxbury Institute. “Chronic joint pain is a prevalent issue affecting thousands of individuals, and Dr. Price is at the forefront of both surgical and non-surgical solutions to the issue.”
Dr. Price will be showcasing the institute’s new FDA-approved cell therapy treatment for degenerative joint conditions. The educational event will be open to all current and potential patients of The Roxbury Institute.
“We’ve built this institute on the unique philosophy that aesthetic care should go hand-in-hand with internal consideration,” said Dr. Amron. “In hosting these educational discussions, we hope to empower patients to always make the best possible choices when it comes to both their aesthetic and internal health concerns.”
The Roxbury Institute is located at 450 North Roxbury Drive, Suite #400 in Beverly Hills, California. For more information or to schedule an appointment, please visit http://www.theroxburyinstitute.com/
Bailey Potter 323.937.1951 [email protected]


Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
FDA Approves Mitapivat for Anemia in Thalassemia Patients
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards 



